In a study, radical prostatectomy for men with Gleason 8-10 prostate cancer and low PSA levels was associated with a lower death risk compared with external beam radiation therapy with or without brachytherapy.
Large observational study reveals a 40% cumulative incidence rate of first skeletal-related events following development of castration-resistant prostate cancer.
The risk of being diagnosed with advanced prostate cancer varies from place to place in the United States, a new study found.
Abiraterone plus prednisone combined with leuprolide decreases tumor size compared with leuprolide alone in men with high-risk prostate cancer.
Older age and high-risk disease are among the factors independently associated with biochemical recurrence of prostate cancer following whole gland cryotherapy.
Using EBRT alone or ADT alone for high-risk localized prostate cancer is associated with worse survival outcomes.
Men who receive androgen deprivation therapy after radical prostatectomy have a nearly 2-fold increased risk of depression compared with those who receive no post-surgical treatment.
In a study, adding docetaxel to androgen deprivation and radiation therapy for selected men with high-risk localized prostate cancer improved overall and metastasis-free survival.
Patients who undergo radical cystectomy for MIBC more than 12 weeks from diagnosis are at increased risk of death, regardless of whether they receive neoadjuvant chemotherapy.
In a phase 3 trial, tenapanor, which reduces paracellular phosphate transport in the intestine, lowered elevated serum phosphorus in patients on hemodialysis.
